Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients

• Main Authors: Chan, T.S.-Y, Lee, Y.-S, Del Giudice, I, Marinelli, M, Ilari, C, Cafforio, L, Guarini, A, Tan, D, Phipps, C, Goh, Y.T, Hwang, W, Goh, A.Z.-K, Siu, L.L.-P, Wu, S, Ha, C.-Y, Lin, S.-Y, Kwok, C.-H, Lau, C.-K, Wong, K.-F, Foà, R, Kwong, Y.-L, Tse, E
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: Impact Journals LLC 2020
• Subjects: chlorambucil; cyclophosphamide; fludarabine; immunoglobulin heavy chain; myeloid differentiation factor 88; Notch1 receptor; rituximab; adult; advanced cancer; age; aged; Article; cancer staging; cancer survival; Chinese; chronic lymphatic leukemia; clinical feature; cohort analysis; controlled study; correlational study; early cancer; female; fluorescence in situ hybridization; follow up; gene sequence; human; IGHV gene; karyotyping; major clinical study; male; molecular pathology; monotherapy; MYD88 gene; NOTCH1 gene; overall survival; progression free survival; somatic mutation; time to treatment; treatment outcome; tumor suppressor gene
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/179763
• Institution: National University of Singapore

10.18632/oncotarget.16037